Upgrade to SI Premium - Free Trial

Nephros, Inc. (NEPH)

3.59 +0.07 (1.99%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form DEF 14A NEPHROS INC For: Oct 14 October 14, 2026 4:02 PM - SEC Filing Form 8-K NEPHROS INC For: Oct 13 October 13, 2026 4:01 PM - SEC Filing Form SCHEDULE 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP September 16, 2026 5:17 PM - SEC Filing Form SCHEDULE 13G NEPHROS INC Filed by: DAVIDSON CHARLES E September 16, 2026 5:11 PM - SEC Filing Form 4 NEPHROS INC For: Sep 14 Filed by: DAVIDSON CHARLES E September 16, 2026 5:06 PM - SEC Filing Form 4 NEPHROS INC For: Sep 14 Filed by: Amron Arthur H September 16, 2026 5:00 PM - SEC Filing Form 4 NEPHROS INC For: Aug 18 Filed by: Wexford GP LLC August 20, 2026 4:15 PM - SEC Filing Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results August 18, 2026 9:20 AM - StreetInsider Form 4 NEPHROS INC For: Aug 12 Filed by: Amron Arthur H August 14, 2026 4:10 PM - SEC Filing Form 10-Q NEPHROS INC For: Jun 30 August 10, 2026 4:01 PM - SEC Filing Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 August 6, 2026 4:10 PM - Globe NewsWire Form 8-K NEPHROS INC For: Aug 06 August 6, 2026 4:02 PM - SEC Filing Nephros Schedules Second Quarter 2026 Financial Results Conference Call August 5, 2026 4:00 PM - Globe NewsWire Full Article List